CD274 and neoplasm: Inhibiting the activity of the protein WNK lysine deficient protein kinase 3 (WNK3) boosts anti-tumor immunity by suppressing the production of another protein (PD-L1) whose activity promotes the programmed cell death of immune system T cells.